Aminocaproic Acid NDC 80005-130

NDC codes

FDA NDC Directory

Product NDC (as listed)80005-130Labeler and product segments. Claims need a package NDC.

Product NDC at billing width80005-0130Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
80005-130-22	80005013022	236.5 mL in 1 BOTTLE (80005-130-22)Marketed from Mar 18, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aminocaproic Acid
Generic name (nonproprietary): aminocaproic acid
Active ingredients: Aminocaproic acid — .25 g/mL
Dosage form: Solution
Route: Oral
Labeler: Carnegie Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214140
Marketing start: Mar 18, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Fibrinolysis (Physiologic effect)
Identifiers: Product ID 80005-130_acb7cc2c-2aea-4c13-96b5-e2d1840ea1d2SPL ID acb7cc2c-2aea-4c13-96b5-e2d1840ea1d2SPL set ID 0d6560a3-c67e-428e-b9b8-fab538856b41RxCUI 582299UNII U6F3787206UPC 0380005130224
Pharmacologic class: Antifibrinolytic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N480005013022 followed by a unit qualifier and the quantity

Package 80005-0130-22. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 5, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Aminocaproic acid is useful in enhancing hemostasis when fibrinolysis contributes to bleeding. In life- threatening situations, transfusion of appropriate blood products and other emergency measures may be required. Fibrinolytic bleeding may frequently be associated with surgical complications following heart surgery (with or without cardiac bypass procedures) and portacaval shunt; hematological disorders such as amegakaryocytic thrombocytopenia (accompanying aplastic anemia); acute and life-threatening abruptio placentae; hepatic cirrhosis; and neoplastic disease such as carcinoma of the prostate, lung, stomach, and cervix. Urinary fibrinolysis, usually a normal physio…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214140

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214140
Product	Strength	Form · route	Labeler	Product NDC
Aminocaproic Acid	Aminocaproic acid .25 g/mL	SolutionOral	Biocon Pharma Inc.	70377-104
Aminocaproic Acid	Aminocaproic acid .25 g/mL	SolutionOral	Bryant Ranch Prepack	72162-2646